PDM Alert for Postoperative Delirium
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a "PDM Alert" (a notification system) can reduce the risk of delirium (confusion and disorientation) after surgery and prevent long-term cognitive issues like dementia. The trial compares patients with this alert on their medical records to those without it. It targets individuals aged 65 and older who are scheduled for major surgery with at least a one-day hospital stay. Participants should not have existing cognitive impairments like Alzheimer's or be experiencing withdrawal from alcohol or drugs. As an unphased trial, this study provides participants the chance to contribute to significant research that could enhance postoperative care for older adults.
Do I need to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the PDM Alert is safe?
Research has shown that the PDM Alert treatment helps doctors predict and manage the risk of delirium after surgery. As a tool rather than a drug, PDM Alert has no direct data on side effects and is not expected to cause any physical side effects. This approach aids healthcare providers in identifying the risk of delirium without raising safety concerns.
Researchers are studying the tool to determine if it can reduce the chances of complications like delirium after surgery. Since it is not a medication, typical concerns about drug side effects do not apply. Instead, the focus is on enhancing patient monitoring and management.12345Why are researchers excited about this trial?
Researchers are excited about the PDM Alert for postoperative delirium because it introduces a novel approach to prevention and management by utilizing a digital alert system. Unlike traditional treatments like medication adjustments and environmental interventions, the PDM Alert places a proactive notification on a patient's record to help healthcare providers identify and address delirium risk factors early. This method could streamline communication among care teams and enhance patient monitoring, potentially improving patient outcomes without relying on additional pharmaceuticals.
What evidence suggests that the PDM Alert is effective for reducing postoperative delirium?
Research shows that confusion after surgery, known as postoperative delirium, is common and affects about 19% of patients undergoing planned surgeries. This highlights the need for effective detection methods. Studies have found that severe delirium can accelerate mental decline and increase the risk of developing dementia. Reducing the severity of delirium might lower these risks. Early results suggest that alerts, such as the PDM Alert, could aid in identifying and managing delirium. In this trial, participants will either have the PDM Alert placed on their record or not, to evaluate its effectiveness. Although more information is needed, these alerts might reduce the frequency and severity of delirium after surgery.13678
Are You a Good Fit for This Trial?
This trial is for individuals who are at least 65 years old and scheduled for major inpatient surgery that requires staying in the hospital for one or more days. It's not suitable for those who don't meet these criteria.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo major abdominal surgery and are monitored for delirium incidence using CAM ICU and 3D-CAM assessments
Follow-up
Participants are monitored for long-term cognitive decline and dementia, and provider satisfaction is assessed
What Are the Treatments Tested in This Trial?
Interventions
- PDM Alert
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor
National Institute on Aging (NIA)
Collaborator